HomeVNDA • NASDAQ
Vanda Pharmaceuticals Inc.
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 53.19M | 17.48% |
Operating expense | 60.87M | 24.47% |
Net income | -4.91M | -104.67% |
Net profit margin | -9.24 | -74.34% |
Earnings per share | — | — |
EBITDA | -8.31M | -39.93% |
Effective tax rate | 24.40% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 374.64M | -3.51% |
Total assets | 656.20M | 1.20% |
Total liabilities | 117.66M | 13.65% |
Total equity | 538.55M | — |
Shares outstanding | 58.32M | — |
Price to book | 0.49 | — |
Return on assets | -3.95% | — |
Return on capital | -4.67% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.91M | -104.67% |
Cash from operations | -1.82M | 51.31% |
Cash from investing | 3.99M | 109.12% |
Cash from financing | -155.00K | — |
Net change in cash | 1.82M | 103.84% |
Free cash flow | -9.57M | 90.91% |
Previous close
$4.50
Day range
$4.41 - $4.50
Year range
$3.99 - $6.75
Market cap
258.63M USD
Avg Volume
657.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Headquarters
Website
Employees
368
